Boasting A 28% Return On Equity, Is DexCom, Inc. (NASDAQ:DXCM) A Top Quality Stock?
Tesla, AT&T, Alphabet, Chipotle, Visa, and More Stocks to Watch This Week
Second-quarter earnings season continues with Verizon, Alphabet, Coca-Cola, Comcast, General Motors, Tesla, Visa, AT&T, Chipotle, and Newmont.
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott Laboratories (NYSE:ABT) CEO Robert Ford said the company will use a mix of TV advertisements and guerilla marketing to promote the U.S. launch of Lingo, its glucose monitoring device.This
Leerink Adjusts Price Target on DexCom to $151 From $161
DexCom (DXCM) has an average outperform rating and a price target range of $105 to $170, according to analysts polled by Capital IQ.Price: 115.41, Change: -0.65, Percent Change: -0.56
Express News | Dexcom Inc : Leerink Partners Cuts Target Price to $151 From $161
The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific
DexCom Is Maintained at Equal-Weight by Morgan Stanley
DexCom Is Maintained at Equal-Weight by Morgan
DexCom Price Target Cut to $120.00/Share From $132.00 by Morgan Stanley
DexCom Price Target Cut to $120.00/Share From $132.00 by Morgan
Express News | Morgan Stanley Maintains Equal-Weight on DexCom, Lowers Price Target to $120
Insiders At DexCom Sold US$18m In Stock, Alluding To Potential Weakness
Here's Why DexCom (DXCM) Is a Strong Growth Stock
Express News | Dexcom Inc : Morgan Stanley Cuts Target Price to $120.00 From $132.00
Morgan Stanley Maintains DexCom(DXCM.US) With Hold Rating, Cuts Target Price to $120
Morgan Stanley analyst Patrick Wood maintains $DexCom(DXCM.US)$ with a hold rating, and adjusts the target price from $122 to $120.According to TipRanks data, the analyst has a success rate of 51.4%
Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H
The Medical Instruments industry is highly fragmented, with participants engaged in research and development (R&D) in therapeutic areas.
Morgan Stanley Cuts Price Target on DexCom to $120 From $132, Keeps Equalweight Rating
DexCom (DXCM) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $105 to $170.Price: 114.66, Change: +0.60, Percent Change: +0.53
DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy
Over the past year, many DexCom, Inc. (NASDAQ:DXCM) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more
Earnings Preview: What to Expect From DexCom's Report
DexCom Is Maintained at Buy by Stifel
DexCom Is Maintained at Buy by
DexCom Price Target Cut to $132.00/Share From $145.00 by Stifel
DexCom Price Target Cut to $132.00/Share From $145.00 by
Stifel Maintains Buy on DexCom, Lowers Price Target to $132
Stifel analyst Mathew Blackman maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $145 to $132.